Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.38% |
| 2 | Healthcare | 7.46% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.11% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
PUT
Insulet
PODD
$9.94B
| $9.54M | ﹤0.01% |
33,100
+31,100
| +1,555% | +$9.45M |
|
2027
Coherent
COHR
$57.6B
| $9.54M | ﹤0.01% |
187,152
-98,535
| -34% | -$3.66M |
|
2028
CALL
McKesson
MCK
$105B
| $9.53M | ﹤0.01% |
22,300
+2,500
| +13% | +$961K |
|
2029
iShares MSCI USA Min Vol Factor ETF
USMV
$24.4B
| $9.47M | ﹤0.01% |
127,392
-30,650
| -19% | -$2.24M |
|
|
CSGS
2030
DELISTED
CSG Systems International
CSGS
| $9.46M | ﹤0.01% |
179,420
-323,497
| -64% | -$16.5M |
|
2031
MiMedx Group
MDXG
$644M
| $9.43M | ﹤0.01% |
1,427,032
+1,373,237
| +2,553% | +$7M |
|
2032
Emergent Biosolutions
EBS
$306M
| $9.42M | ﹤0.01% |
1,282,274
+876,273
| +216% | +$8.13M |
|
2033
Brookdale Senior Living
BKD
$2.91B
| $9.4M | ﹤0.01% |
2,226,454
-437,186
| -16% | -$1.69M |
|
2034
PUT
Copart
CPRT
$30.2B
| $9.39M | ﹤0.01% |
206,000
+200,200
| +3,452% | +$8.3M |
|
|
DMC
2035
Del Monte Corp
DMC
$1.49B
| $9.39M | ﹤0.01% |
365,302
+224,074
| +159% | +$6.18M |
|
2036
Opko Health
OPK
$1.13B
| $9.39M | ﹤0.01% |
4,326,865
-2,094,967
| -33% | -$3.28M |
|
2037
CALL
Arbor Realty Trust
ABR
$944M
| $9.38M | ﹤0.01% |
633,100
+133,100
| +27% | +$1.65M |
|
2038
NET Power
NPWR
$160M
| $9.38M | ﹤0.01% |
721,726
-485,529
| -40% | -$5.4M |
|
2039
CALL
Silgan Holdings
SLGN
$4.54B
| $9.38M | ﹤0.01% |
+200,000
| New | +$9.73M |
|
2040
Replimune Group
REPL
$1.5B
| $9.38M | ﹤0.01% |
403,873
-184,088
| -31% | -$3.6M |
|
2041
PUT
Hewlett Packard
HPE
$73.1B
| $9.37M | ﹤0.01% |
557,800
+515,200
| +1,209% | +$7.88M |
|
2042
PUT
Okta
OKTA
$23.4B
| $9.36M | ﹤0.01% |
+134,900
| New | +$10.2M |
|
2043
Alamos Gold
AGI
$15.7B
| $9.34M | ﹤0.01% |
783,865
+168,884
| +27% | +$2.15M |
|
2044
CALL
Akamai
AKAM
$15.5B
| $9.34M | ﹤0.01% |
103,900
+99,200
| +2,111% | +$8.5M |
|
2045
Mercer International
MERC
$27.7M
| $9.33M | ﹤0.01% |
1,156,741
+450,051
| +64% | +$4.09M |
|
2046
N-able
NABL
$718M
| $9.33M | ﹤0.01% |
647,779
+439,194
| +211% | +$6.08M |
|
2047
Bentley Systems
BSY
$11.2B
| $9.32M | ﹤0.01% |
171,835
-13,357
| -7% | -$623K |
|
2048
ArcBest
ARCB
$3.11B
| $9.32M | ﹤0.01% |
94,304
-28,687
| -23% | -$2.56M |
|
2049
Universal Insurance Holdings
UVE
$1.22B
| $9.31M | ﹤0.01% |
603,251
+391,090
| +184% | +$6.48M |
|
2050
Academy Sports + Outdoors
ASO
$2.7B
| $9.31M | ﹤0.01% |
172,188
+10,333
| +6% | +$594K |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.